Pituitary Apoplexy, A Review
Arch Neurol 42:712-719, Reid,R.L.,et al, 1985
Neurological Problems in Endocrine Diseases
Med Clin North Am 56:1029, Dale,A., 1972
An Unusual Presentation of Prolonged Delirium
BMJ 373:N1423, Bume, R.,et al, 2021
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months
Medicine 84:188-196, Imboden,E.,e tal, 2005
An Unusual Case of Growth Retardation
Lancet 366:520, Faleschini,E.,et al, 2005
Lymphoma Metastasizing to the Pituitary: An Unusual Presentation of a Treatable Disease
Pituitary 8:139-146, Ogilvie, C.M.,et al, 2005
Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Primary Sellar Lymphoma:Radiologic and Pathologic Findings in Two Patients
AJNR 23:364-367, Kaufmann,T.J.,et al, 2002
Clinicopath Conf., Prolactinoma
NEJM 347:1604-1611, Case 35-2002, 2002
Narcolepsy Associated with Other Central Nervous System Disorders
Neurol 57:539-541, Malik,S.,et al, 2001
Clinicopath Conf, Non-Small-Cell Carcinoma of Lung, Metastatic to Hypothalamus, Pituitary Stalk and Pituitary Gland
NEJM 345:1483-1495, Case 35-2001, 2001
Long-term Treatment of Acromegaly With Pegvisomant, a Growth Hormone Receptor Antagonist
Lancet 358:1754-1759,1743, van der Lely,A.J.,et al, 2001
Primary Lymphoma of the Pituitary: An Emerging Clinical Entity
J Clin Endocrinol Metab 86:4567-4575, Giustina,A.,et al, 2001
Pituitary Lymphoma Presenting as Fever of Unknown Origin
J Clin Endocrinol Metab 86:1470-1476, Landman, R.E.,et al, 2001
Treatment of Acromegaly With the Growth Hormone-Receptor Antagonist Pegvisomant
NEJM 342:1171-1177,1210, Trainer,P.J.,et al, 2000
Diagnosis, Treatment, and Outcome of Pituitary Tumors and Other Abnormal Intrasellar Masses, Retrospective Analysis of 353 Patients
Medicine 78:236-269, Gsponer,J.,et al, 1999
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
A Case of Sellar T Cell Type Malignant Lymphoma
No Shinkei Geka 26:53-58, Sakakibara,Y.,et al, 1998
The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease
NEJM 336:172-177, 2151997., Estrada,J.,et al, 1997
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Complications of Transsphenoidal Surgery:Results of a National Survey, Review of the Literature, and Personal Experience
Neurosurg 40:225-236, Ciric,I.,et al, 1997
Arterial Injuries in Transsphenoidal Surgery for Pituitary Adenoma:The Role of Angiography and Endovascular Treatment
ANJR 18:655-665, Raymond,J.,et al, 1997
Octreotide
NEJM 334:246-254, Lamberts,S.W.J.,et al, 1996
Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996
The Natural History of the Pituitary Incidentaloma
Arch Int Med 155:181-183, Donovan,L.E.&Corenblum,B., 1995
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Octreotide Therapy for Thyroid-Stimulation Hormone-Secreting Pituitary Adenomas, A Follow-up of 52 Patients
Ann Int Med 119:236-240, Chanson,P.,et al, 1993
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Comprehensive Study of Diagnosis and Treatment of Trigeminal Neuralgia Secondary to Tumors
Neurol 43:2298-2302, Cheng,T.M.W.,et al, 1993
Twelve Cases of Pituitary Apoplexy
Arch Int Med 152:1893-1899, Vidal,E.,et al, 1992
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Long-term Treatment of 189 Acromegalic Patients with the Somatostatin Analog Octreotide
Arch Int Med 151:1573-1578, Vance,M.L.&Harris,A.G., 1991
Mortality, Neoplasia, & Creutzfeldt-Jakob Disease in Patients Treated with Human Pituitary Growth Hormone in the UK
BMJ 302:824-828, Buchanan,C.R.,et al, 1991
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
The'Incidentaloma'of the Pituitary Gland is Neurosurgery Required
JAMA 263:2772-2776, Reincke,M.,et al, 1990
The Pituitary"Incidentaloma"
Ann Int Med 112:925-931, Molitch,M.E.&Russell,E.J., 1990
Pituitary Adenoma in McCune-Albright Syndrome:MR Demonstration
J Comput Assist Tomogr 13:685-688, O'Laughlin,R.L.,et al, 1989
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201-995
NEJM 313:1576-1580, 1604-16051985., Lamberts,S.W.J.,et al, 1985
Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982
Bromocriptine in Management of Large Pituitary Tumours
BMJ 284:1908-1911, Wass,J.A.H.,et al, 1982
Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979